An Antimitotic and Antivascular Agent BPR0L075 Overcomes Multidrug Resistance and Induces Mitotic Catastrophe in Paclitaxel-Resistant Ovarian Cancer Cells

• Xiaolei Wang,

  Affiliation Department of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, Texas, United States of America

  ⨯
• Erxi Wu,

  Affiliation Department of Pharmaceutical Sciences, North Dakota State University, Fargo, North Dakota, United States of America

  ⨯
• Jun Wu,

  Affiliation Division of Comparative Medicine, Beckman Research Institute of the City of Hope, Duarte, California, United States of America

  ⨯
• Tian-Li Wang,

  Affiliation Departments of Gynecology/Obstetrics and Oncology, Johns Hopkins University, Baltimore, Maryland, United States of America

  ⨯
• Hsing-Pang Hsieh,

  Affiliation Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Taipei, Taiwan, Republic of China

  ⨯
• Xinli Liu

  * E-mail: xinli.liu@ttuhsc.edu

  Affiliation Department of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, Texas, United States of America

  ⨯